PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 12 filers reported holding PHIO PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -88.7% | 11,600 | -81.4% | 0.00% | – |
| Q4 2021 | $62,000 | -82.2% | 62,397 | -63.7% | 0.00% | – |
| Q3 2021 | $348,000 | -43.0% | 171,748 | -36.4% | 0.00% | – |
| Q2 2021 | $611,000 | +76.6% | 269,944 | +109.1% | 0.00% | – |
| Q1 2021 | $346,000 | +1230.8% | 129,072 | +959.9% | 0.00% | – |
| Q3 2020 | $26,000 | – | 12,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 35,929 | $77,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 21,278 | $46,000 | 0.01% |
| UBS Group AG | 566 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HSBC HOLDINGS PLC | 11,337 | $24,000 | 0.00% |
| BlackRock Inc. | 19 | $0 | 0.00% |
| Citadel Advisors | 12,178 | $26,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 581 | $1,000 | 0.00% |